Regulatory Affairs
Learn more about our Regulatory Affairs work.
FDA Response Letter to AdvaMed®’s UDI Cross Reference Proposal
FDA sent this letter in response to issues AdvaMed® raised to the FDA regarding implementation of the UDI rule.
Learn more about our Regulatory Affairs work.
FDA sent this letter in response to issues AdvaMed® raised to the FDA regarding implementation of the UDI rule.